Wetenschappelijke publicaties 2019 - Klinisch laboratorium

Added Value of Fecal Calprotectin to Support the Diagnosis of Spondyloarthropathies.
Van Hoovels L1, VAN DEN Bremt S2, Schiemsky T2, Cauchie M2,Vander Cruyssen B3, Bossuyt X4,VAN DER Steen K5, Stubbe M6.
J Rheumatol. 2019 Feb;46(2):215-216. doi: 10.3899/jrheum.180432.

Harmonizing by reducing inter-run variability: performance evaluation of a quality assurance program for antinuclear antibody detection by indirect immunofluorescence.
Bogaert L, Van den Bremt S, Schouwers S, Bossuyt X, Van Hoovels L.
Clin Chem Lab Med. 2019 Jun 26;57(7):990-998. doi: 10.1515/cclm-2018-0933. PMID: 30838836

Fluorescent in situ hybridization can be used as a complementary assay for the diagnosis of Tropheryma whipplei infection.
Prudent E, Le Guenno G, Jonckheere S, Vankeerberghen A, Lepidi H, Angelakis E, Raoult D.
Infection. 2019 Apr;47(2):317-321. doi: 10.1007/s15010-018-1243-0. Epub 2018 Oct 27. PMID: 30368732

Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI).
Bogaert L, Schiemsky T, Van Hover P, De Schrijver P, Van Hoovels L.
Clin Chem Lab Med.2019 Feb 2. pii: /j/cclm.ahead-of-print/cclm-2018-1105/cclm-2018-1105.xml. doi: 10.1515/cclm-2018-1105. [Epub ahead of print] No abstract available. PMID: 307104

Harmonisation of laboratory tests for rheumatic diseases: still a long way to go.
Van Hoovels L, Bossuyt X.
Ann Rheum Dis.2018 Dec 4. pii: annrheumdis-2018-214696. doi: 10.1136/annrheumdis-2018-214696. [Epub ahead of print] No abstract available. PMID: 30514700

 Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.
Deconinck S1, Tersteeg C1, Bailleul E2, Delrue L2, Vandeputte N1, Pareyn I1, Itzhar-Baikian N3, Deckmyn H1, De Meyer SF1, Vanderheyden M2, Vanhoorelbeke K1.
Res Pract Thromb Haemost. 2018 Oct 8;2(4):762-766. doi: 10.1002/rth2.12150. eCollection 2018 Oct.

Target Controlled Infusion of cefepime in critically ill patients: single center experience.
Jonckheere S, De Neve N, Verbeke J, De Decker K, Brandt I, Boel A, Van Bocxlaer J, Struys MMRF, Colin PJ.
Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01552-19. doi: 10.1128/AAC.01552-19. [Epub ahead of print] PMID: 31685467

Acquired von Willebrand syndrome in patients on long-term left ventricular assist device support: Results of a Belgian center.
Deconinck SJ, Tersteeg C, Bailleul E, Delrue L, Vandeputte N, Pareyn I, Deckmyn H, De Meyer SF, Vanhoorelbeke K, Vanderheyden M.
Thromb Res. 2019 Oct 21;184:77-80. doi: 10.1016/j.thromres.2019.10.012. [Epub ahead of print] No abstract available. PMID: 31710861

Titre-specific positive predictive value of antinuclear antibody patterns.
Vulsteke JB, Van Hoovels L, Willems P, Vander Cruyssen B, Vanderschueren S, Westhovens R, Blockmans D, De Langhe E, Bossuyt X.
Ann Rheum Dis. 2019 Oct 10. pii: annrheumdis-2019-216245. doi: 10.1136/annrheumdis-2019-216245. [Epub ahead of print] No abstract available. PMID: 31601627

Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis.
Van Hoovels L, Vander Cruyssen B, Bogaert L, Van den Bremt S, Bossuyt X.
Clin Chem Lab Med.2019 Oct 30. pii: /j/cclm.ahead-of-print/cclm-2019-0508/cclm-2019-0508.xml. doi: 10.1515/cclm-2019-0508. [Epub ahead of print] PMID: 31665107

Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon.
Frans G, Meeus P, Bailleul E.
J Thromb Haemost. 2019 Aug;17(8):1354-1362. doi: 10.1111/jth.14488. Epub 2019 Jun 12.